Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice
Physiological Reports · 2025-02 · 13 (3)
DOI: 10.14814/phy2.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, online erschienen am 30.01.2025. Verfasst von Kunihiko Takahara und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Butyrates, Ketone Bodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research A, Takeda Science Foundation (TSF), Grant-in-Aid for Scientific Research C.
Abstract (Originalsprache)
Chronic kidney disease is a life‐threatening disease worldwide. PPARα is a crucial transcriptional regulator of lipid metabolism and inflammation. Here, we examine whether a novel selective PPARα modulator, pemafibrate modulates renal injury in a model of unilateral ureteral obstruction (UUO). Administration of pemafibrate to wild‐type (WT) mice led to reduction of renal dysfunction and fibrosis after UUO with accompanying increases in plasma levels of fibroblast growth factor (FGF) 21 and ketone body β‐hydroxybutyrate (BHB). Treatment of WT mice with FGF21 or BHB precursor resulted in attenuation of renal fibrotic and inflammatory responses after UUO. Treatment of proximal tubular cells with FGF21 or BHB reduced expression of epithelial–mesenchymal transition markers. These findings suggest that pemafibrate could ameliorate renal damage, at least in part, by its abilities to increase the production of FGF21 and BHB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Molecular Medicine and Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
ORCID-Profile: Yoshimitsu Yura, Koji Ohashi
Förderung
- Grant-in-Aid for Scientific Research A
- Takeda Science Foundation (TSF)
- Grant-in-Aid for Scientific Research C
Zitieren
APA
Takahara, K., Ouchi, N., Takikawa, T., Ozaki, Y., Fang, L., Kawanishi, H., Tatsumi, M., Yura, Y., Kato, K., Takefuji, M., Murohara, T., & Ohashi, K. (2025). Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice. Physiological Reports, 13(3). https://doi.org/10.14814/phy2.70135
Vancouver
Takahara K, Ouchi N, Takikawa T, Ozaki Y, Fang L, Kawanishi H, et al. Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice. Physiological Reports. 2025;13(3). doi:10.14814/phy2.70135
BibTeX
@article{Takahara2025,
author = {Takahara, Kunihiko and Ouchi, Noriyuki and Takikawa, Tomonobu and Ozaki, Yuta and Fang, Lixin and Kawanishi, Hiroshi and Tatsumi, Minako and Yura, Yoshimitsu and Kato, Katsuhiro and Takefuji, Mikito and Murohara, Toyoaki and Ohashi, Koji},
title = {Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice},
journal = {Physiological Reports},
year = {2025},
volume = {13},
number = {3},
doi = {10.14814/phy2.70135}
}
EUVIMED